Clinical trialNCT02406677CompletedPhase 4Interventional

Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study

SponsorAstraZenecaEnrollment11,001Cost Sharing, Acute Coronary Syndrome

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Eric Peterson, MD, MPH, FAHA, FACC
Duke University
Study Chair
clinicaltrials.gov ↗
Tracy Wang, MD, MHS, MSc
Duke University
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

272 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico

Research Site
Caguas, Puerto Rico

United States

Research Site
Birmingham, Alabama, United States
Research Site
Huntsville, Alabama, United States
Research Site
Mobile, Alabama, United States
Research Site
Mobile, Alabama, United States
Research Site
Anchorage, Alaska, United States
Research Site
Cottonwood, Arizona, United States
Research Site
Flagstaff, Arizona, United States
Research Site
Phoenix, Arizona, United States
Research Site
Fayetteville, Arkansas, United States
Research Site
Fort Smith, Arkansas, United States
Research Site
Jonesboro, Arkansas, United States
Research Site
Little Rock, Arkansas, United States
Research Site
Escondido, California, United States
Research Site
Huntington Beach, California, United States
Research Site
Loma Linda, California, United States
Research Site
Los Angeles, California, United States
Research Site
Los Angeles, California, United States
Research Site
Northridge, California, United States
Research Site
Pasadena, California, United States
Research Site
Riverside, California, United States
Research Site
Salinas, California, United States
Research Site
Stockton, California, United States
Research Site
Thousand Oaks, California, United States
Research Site
Torrance, California, United States
Research Site
Vista, California, United States
Research Site
Aurora, Colorado, United States
Research Site
Aurora, Colorado, United States
Research Site
Colorado Springs, Colorado, United States
Research Site
Denver, Colorado, United States
Research Site
Bridgeport, Connecticut, United States
Research Site
Danbury, Connecticut, United States
Research Site
New Haven, Connecticut, United States
Research Site
Stamford, Connecticut, United States
Research Site
Boynton Beach, Florida, United States
Research Site
Bradenton, Florida, United States
Research Site
Bradenton, Florida, United States
Research Site
Daytona Beach, Florida, United States
Research Site
Gainesville, Florida, United States
Research Site
Hollywood, Florida, United States

232 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 5 Jun 2015
Primary completion: 23 Oct 2017
Completion: 23 Oct 2017
Last update posted: 1 Oct 2019
Registered enrollment: 11,001
Registry id: NCT02406677

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.